About

About

PMC's Annual Award for Leadership in Personalized Medicine

Nomination Period Closed

The Personalized Medicine Coalition is no longer accepting nominations for the 16th Annual Award for Leadership in Personalized Medicine.

Thank you to all those who submitted a leader for consideration.

PMC will present the award to this year's winner during the 16th Annual Personalized Medicine Conference at Harvard Medical School. The recipient will share his or her vision for the future of personalized medicine with conference attendees.

About the Award

The Annual Award for Leadership in Personalized Medicine recognizes an individual whose contributions in science, business and policy have helped advance the frontiers of personalized medicine.

Previous award recipients include:

  • Steven Shak, M.D. (2019)
    Co-Founder
    Genomic Health
  • Ellen V. Sigal, Ph.D. (2018)
    Chairperson, Founder
    Friends of Cancer Research
  • Jay T. Flatley (2017)
    Executive Chairman
    Illumina
  • Raju Kucherlapati, Ph.D. (2016)
    Paul C. Cabot Professor of Genetics
    Harvard Medical School
  • Francis S. Collins, M.D., Ph.D. (2015)
    Director
    National Institutes of Health (NIH)
  • Mark Levin (2014)
    Co-founder, Partner
    Third Rock Ventures
  • Kathy Giusti (2013)
    Founder, Chief Executive Officer
    Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
  • Randal W. Scott, Ph.D. (2012)
    Co-Founder
    InVitae Corporation
  • Leroy Hood, Ph.D., M.D. (2011)
    President
    Institute for Systems Biology
  • William S. Dalton, Ph.D., M.D. (2010)
    CEO
    M2GEN
    Director
    DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center
  • Brook Byers (2009)
    Managing Partner
    Kleiner Perkins Caufield & Byers (KPCB)
  • Michael O. Leavitt (2008)
    Founder and Chairman
    Leavitt Partners
  • Ralph Snyderman, M.D. (2007)
    Chancellor Emeritus
    Duke University
    Founder and Chairman
    Proventys, Inc.
  • Elizabeth G. Nabel, M.D. (2006)
    President
    Brigham and Women's Health Care
  • Janet Woodcock, M.D. (2005)
    Director
    FDA Center for Drug Evaluation and Research